Mesoblast rattles tin for at least $37m with Bell Potter
MELBOURNE: Mesoblast, the local biotech developing treatments for cardiovascular disease and back pain, is no
MELBOURNE: Mesoblast, the local biotech developing treatments for cardiovascular disease and back pain, is no
FEATURED
Residential care operator solves shortage of health sector staff issue
Study highlights lack of nursing home medical director presence
Entity in court battle over bots trolling nursing home data
Unique sheltered housing project now revolutionizing retirement for expats
Multigenerational well-being community proposed for power station site
Arts in Health trial could hold key to faster patient recovery
INNOVATION
